Edgar Filing: OWENS & MINOR INC/VA/

OMI 6.30.2015-10Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________________________________________________

FORM 10-Q

________________________________________________



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2015



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-9810

_______________________________________________________

Owens & Minor, Inc.

(Exact name of Registrant as specified in its charter)

_______________________________________________________



Virginia	54-1701843
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

9120 Lockwood Boulevard, Mechanicsville, Virginia	23116
(Address of principal executive offices)	(Zip Code)

Post Office Box 27626, Richmond, Virginia	23261-7626
(Mailing address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code (804) 723-7000

_________________________________________________________

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “larger accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	o (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares of Owens & Minor, Inc.’s common stock outstanding as of July 24, 2015, was 63,018,058 shares.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Index



Part I. Financial Information		Page

Item 1.	Financial Statements	3
	Consolidated Statements of Income—Three and Six Months Ended June 30, 2015 and 2014	3
	Consolidated Statements of Comprehensive Income—Three and Six Months Ended June 30, 2015 and 2014	4
	Consolidated Balance Sheets—June 30, 2015 and December 31, 2014	5
	Consolidated Statements of Cash Flows—Six Months Ended June 30, 2015 and 2014	6
	Consolidated Statements of Changes in Equity—Six Months Ended June 30, 2015 and 2014	7
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	30
Item 4.	Controls and Procedures	30
Part II. Other Information
Item 1.	Legal Proceedings	30
Item 1A.	Risk Factors	30
Item 2.	Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities	31
Item 6.	Exhibits	33

Table of Contents

Part I. Financial Information

Item 1. Financial Statements

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Income

(unaudited)



	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands, except per share data)	2015			2014			2015			2014
Net revenue	$	2,422,167		$	2,305,858		$	4,813,363		$	4,562,239
Cost of goods sold	2,123,830			2,023,586			4,217,425			3,998,771
Gross margin	298,337			282,272			595,938			563,468
Selling, general and administrative expenses	231,498			225,838			465,323			451,448
Acquisition-related and exit and realignment charges	5,707			7,593			15,623			10,855
Depreciation and amortization	15,460			13,892			31,329			27,756
Other operating income, net	(2,188		)	(2,152		)	(5,172		)	(9,978		)
Operating earnings	47,860			37,101			88,835			83,387
Interest expense, net	6,680			3,342			13,560			6,589
Income before income taxes	41,180			33,759			75,275			76,798
Income tax provision	16,954			13,883			32,109			31,436
Net income	$	24,226		$	19,876		$	43,166		$	45,362
Net income per common share:
Basic	$	0.39		$	0.32		$	0.69		$	0.72
Diluted	$	0.39		$	0.32		$	0.69		$	0.72
Cash dividends per common share	$	0.2525		$	0.25		$	0.505		$	0.50

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income

(unaudited)



	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands)	2015			2014			2015			2014
Net income	$	24,226		$	19,876		$	43,166		$	45,362
Other comprehensive income (loss), net of tax:
Currency translation adjustments (net of income tax of $0 in 2015 and 2014)	6,606			(570		)	(21,335		)	(103		)
Change in unrecognized net periodic pension costs (net of income tax of $141 and $285 in 2015 and $90 and $186 in 2014)	260			112			518			219
Other (net of income tax of $0 in 2015 and $8 and $16 in 2014)	(8		)	15			30			6
Total other comprehensive income (loss), net of tax	6,858			(443		)	(20,787		)	122
Comprehensive income	$	31,084		$	19,433		$	22,379		$	45,484

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Balance Sheets

(unaudited)



	June 30,			December 31,
(in thousands, except per share data)	2015			2014
Assets
Current assets
Cash and cash equivalents	$	200,969		$	56,772
Accounts and notes receivable, net of allowances of $13,220 and $13,306	580,739			626,192
Merchandise inventories	903,501			872,457
Other current assets	275,481			315,285
Total current assets	1,960,690			1,870,706
Property and equipment, net of accumulated depreciation of $173,278 and $163,377	219,372			232,979
Goodwill, net	421,760			423,276
Intangible assets, net	100,904			108,593
Other assets, net	92,180			99,852
Total assets	$	2,794,906		$	2,735,406
Liabilities and equity
Current liabilities
Accounts payable	$	753,495		$	608,846
Accrued payroll and related liabilities	34,797			31,507
Deferred income taxes	41,378			37,979
Other accrued liabilities	288,432			326,223
Total current liabilities	1,118,102			1,004,555
Long-term debt, excluding current portion	574,623			608,551
Deferred income taxes	62,282			63,901
Other liabilities	62,772			67,561
Total liabilities	1,817,779			1,744,568
Commitments and contingencies
Equity
Owens & Minor, Inc. shareholders’ equity:
Common stock, par value $2 per share; authorized - 200,000 shares; issued and outstanding - 63,018 shares and 63,070 shares	126,036			126,140
Paid-in capital	205,727			202,934
Retained earnings	690,152			685,765
Accumulated other comprehensive income	(44,788		)	(24,001		)
Total equity	977,127			990,838
Total liabilities and equity	$	2,794,906		$	2,735,406

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(unaudited)



	Six Months Ended June 30,
(in thousands)	2015			2014
Operating activities:
Net income	$	43,166		$	45,362
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	36,138			27,756
Share-based compensation expense	5,048			4,190
Provision for losses on accounts and notes receivable	41			334
Deferred income tax (benefit) expense	2,992			(5,151		)
Changes in operating assets and liabilities:
Accounts and notes receivable	41,622			28,477
Merchandise inventories	(31,866		)	(48,575		)
Accounts payable	145,682			54,922
Net change in other assets and liabilities	2,771			(32,765		)
Other, net	1,196			(1,078		)
Cash provided by operating activities	246,790			73,472
Investing activities:
Additions to property and equipment	(12,009		)	(25,657		)
Additions to computer software and intangible assets	(10,816		)	(13,166		)
Proceeds from sale of investment	—			1,937
Proceeds from sale of property and equipment	837			45
Cash used for investing activities	(21,988		)	(36,841		)
Financing activities:
Change in bank overdraft	1,530			—
Repayment of revolving credit facility	(33,700		)	—
Cash dividends paid	(31,867		)	(31,564		)
Repurchases of common stock	(7,440		)	(9,448		)
Excess tax benefits related to share-based compensation	457			444
Proceeds from exercise of stock options	—			1,180
Purchase of noncontrolling interest	—			(1,500		)
Other, net	(5,112		)	(4,441		)
Cash used for financing activities	(76,132		)	(45,329		)
Effect of exchange rate changes on cash and cash equivalents	(4,473		)	(1,180		)
Net increase (decrease) in cash and cash equivalents	144,197			(9,878		)
Cash and cash equivalents at beginning of period	56,772			101,905
Cash and cash equivalents at end of period	$	200,969		$	92,027
Supplemental disclosure of cash flow information:
Income taxes paid, net	$	27,542		$	56,837
Interest paid	$	13,260		$	7,402

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Consolidated Statements of Changes in Equity

(unaudited)



	Owens & Minor, Inc. Shareholders’ Equity
(in thousands, except per share data)	Common Shares Outstanding		Common Stock ($ 2 par value )			Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Noncontrolling Interest			Total Equity
Balance December 31, 2013	63,096		$	126,193		$	196,605		$	691,547		$	9,568		$	1,130		$	1,025,043
Net income									45,362									45,362
Other comprehensive income												122						122
Dividends declared ($0.50 per share)									(31,473		)							(31,473		)
Shares repurchased and retired	(277	)	(555		)				(8,893		)							(9,448		)
Share-based compensation expense, exercises and other	247		495			3,109												3,604
Purchase of noncontrolling interest						(695		)							(1,130		)	(1,825		)
Balance June 30, 2014	63,066		$	126,133		$	199,019		$	696,543		$	9,690		$	—		$	1,031,385

Balance December 31, 2014	63,070		$	126,140		$	202,934		$	685,765		$	(24,001	)	$	—		$	990,838
Net income									43,166									43,166
Other comprehensive income												(20,787		)				(20,787		)
Dividends declared ($0.505 per share)									(31,779		)							(31,779		)
Shares repurchased and retired	(220	)	(440		)				(7,000		)							(7,440		)
Share-based compensation expense, exercises and other	168		336			2,793												3,129
Balance June 30, 2015	63,018		$	126,036		$	205,727		$	690,152		$	(44,788	)	$	—		$	977,127

See accompanying notes to consolidated financial statements.

Table of Contents

Owens & Minor, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(unaudited)

(in thousands, unless otherwise indicated)

Note 1—Basis of Presentation and Use of Estimates

Basis of Presentation

The accompanying unaudited consolidated financial statements include the accounts of Owens & Minor, Inc. and the subsidiaries it controls (we, us, or our) and contain all adjustments (which are comprised only of normal recurring accruals and use of estimates) necessary to conform with U.S. generally accepted accounting principles (GAAP). All significant intercompany accounts and transactions have been eliminated. The results of operations for interim periods are not necessarily indicative of the results expected for the full year.

Reclassifications

Certain prior year amounts have been reclassified to conform to current year presentation.

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires us to make assumptions and estimates that affect reported amounts and related disclosures. Actual results may differ from these estimates.

Note 2—Fair Value

The carrying amounts of cash and cash equivalents, accounts receivable, financing receivables, accounts payable and financing payables included in the consolidated balance sheets approximate fair value due to the short-term nature of these instruments. The fair value of long-term debt is estimated based on quoted market prices or dealer quotes for the identical liability when traded as an asset in an active market (Level 1) or, if quoted market prices or dealer quotes are not available, on the borrowing rates currently available for loans with similar terms, credit ratings and average remaining maturities (Level 2). We determine the fair value of our derivatives based on quoted market prices. See Note 8 for the fair value of long-term debt and Note 9 for the fair value of derivatives.

Note 3—Acquisitions

On October 1, 2014, we completed the acquisition of Medical Action Industries Inc. (Medical Action), a leading producer of surgical kits and procedure trays, which enabled an expansion of our capabilities in the assembly of kits, packs and trays for the healthcare market.

On November 1, 2014, we acquired ArcRoyal, a privately held surgical kitting company based in Ireland (ArcRoyal). The transaction expanded our capabilities in the assembly of kits, packs and trays in the European healthcare market.

The combined consideration for these two acquisitions was $261.6 million, net of cash acquired, and including debt assumed of $13.4 million (capitalized lease obligations).

The purchase price was allocated to the underlying assets acquired and liabilities assumed based upon our preliminary estimate of their fair values at the date of acquisition, with certain exceptions permitted under GAAP. The combined purchase price exceeded the preliminary estimated fair value of the net tangible and identifiable intangible assets by $151.3 million, which was allocated to goodwill. The following table presents, in the aggregate, the preliminary estimated fair value of the assets acquired and liabilities assumed recognized as of the acquisition date. Adjustments relate to revised estimates pending completion of our valuation. The allocation of purchase price to assets and liabilities acquired is not yet complete as we are working to finalize the valuation of specific fixed assets and liabilities.

Table of Contents



	Preliminary Fair Value Estimated as of Acquisition Date		Differences Between Prior and Current Period Preliminary Fair Value Estimate			Preliminary Fair Value Currently Estimated as of Acquisition Date
Assets acquired:
Current assets	$	90,608	$	147		$	90,755
Property and equipment	34,048		(1,234		)	32,814
Goodwill	150,492		773			151,265
Intangible assets	77,623		—			77,623
Total assets	352,771		(314		)	352,457
Liabilities assumed:
Current liabilities	64,736		(314		)	64,422
Noncurrent liabilities	26,426		—			26,426
Total liabilities	91,162		(314		)	90,848
Fair value of net assets acquired, net of cash	$	261,609	$	—		$	261,609

We are amortizing the fair value of acquired intangible assets, primarily customer relationships, over their remaining weighted average useful lives of 14 years.

Goodwill of $151.3 million consists largely of expected opportunities to expand our kitting capabilities. We assigned goodwill of $21.9 million to our International segment and $129.4 million to our Domestic segment. None of the goodwill recognized is expected to be deductible for income tax purposes.

Pro forma results of operations for these acquisitions have not been presented because the effects on revenue and net income were not material to our historic consolidated financial statements.

Acquisition-related expenses in 2015 consisted primarily of transition costs incurred to integrate the acquired operations (including certain severance and contractual payments to former management). We recognized pre-tax acquisition-related expenses of $1.8 million in the second quarter and $4.4 million year-to-date in 2015 related to these activities.

Acquisition-related expenses of $3.5 million and $4.1 million in the three and six months ended June 30, 2014 consisted of costs to perform due diligence and analysis related to the Medical Action and ArcRoyal acquisitions, as well as certain costs in Movianto to resolve issues and claims with the former owner.

Note 4—Financing Receivables and Payables

At June 30, 2015 and December 31, 2014, we had financing receivables of $157.5 million and $196.2 million and related payables of $136.5 million and $168.8 million outstanding under our order-to-cash program and product financing arrangements, which were included in other current assets and other current liabilities, respectively, in the consolidated balance sheets.

Note 5—Goodwill and Intangible Assets

The following table summarizes the changes in the carrying amount of goodwill through June 30, 2015:



	Domestic Segment		International Segment			Total
Carrying amount of goodwill, December 31, 2014	$	377,089	$	46,187		$	423,276
Currency translation adjustments	—		(2,289		)	(2,289		)
Acquisitions (see Note 3)	773		—			773
Carrying amount of goodwill, June 30, 2015	$	377,862	$	43,898		$	421,760

Table of Contents

Intangible assets at June 30, 2015, and December 31, 2014, were as follows:



	June 30, 2015						December 31, 2014
	Customer Relationships			Other Intangibles			Customer Relationships			Other Intangibles

Gross intangible assets	$	123,222		$	2,695		$	125,448		$	3,405
Accumulated amortization	(24,905		)	(108		)	(19,773		)	(487		)
Net intangible assets	$	98,317		$	2,587		$	105,675		$	2,918

At June 30, 2015, $63.2 million in net intangible assets were held in the Domestic segment and $37.7 million were held in the International segment. Amortization expense for intangible assets was $2.4 million and $1.1 million for the three months ended June 30, 2015 and 2014 and $4.9 million and $2.2 million for the six months ended June 30, 2015 and 2014.

Based on the current carrying value of intangible assets subject to amortization, estimated amortization expense is $5.0 million for the remainder of 2015, $10.2 million for 2016, $10.0 million for 2017, $9.4 million for 2018, $9.3 million for 2019 and $9.3 million for 2020.

Note 6—Exit and Realignment Costs

We periodically incur exit and realignment and other charges associated with optimizing our operations, which includes the consolidation of certain distribution and logistics centers, administrative offices and warehouses in the United States and Europe. These charges also include costs associated with our strategic organizational realignment which include management changes, certain professional fees and costs to streamline administrative functions and processes.

Exit and realignment charges by segment for the three and six months ended June 30, 2015 and 2014 were as follows:



	Three Months Ended June 30,					Six Months Ended June 30,
	2015			2014		2015		2014
Domestic segment	$	(124	)	$	2,303	$	2,515	$	3,596
International segment	4,045			1,801		8,717		3,131
Total exit and realignment charges	$	3,921		$	4,104	$	11,232	$	6,727

The following table summarizes the activity related to exit and realignment cost accruals through June 30, 2015 and 2014:



	Lease Obligations			Severance and Other			Total
Accrued exit and realignment costs, December 31, 2014	$	3,575		$	2,887		$	6,462
Provision for exit and realignment activities	256			142			398
Cash payments, net of sublease income	(385		)	(873		)	(1,258		)
Accrued exit and realignment costs, March 31, 2015	3,446			2,156			5,602
Provision for exit and realignment activities	572			392			964
Cash payments, net of sublease income	(349		)	(1,171		)	(1,520		)
Accrued exit and realignment costs, June 30, 2015	$	3,669		$	1,377		$	5,046

Accrued exit and realignment costs, December 31, 2013	$	2,434		$	475		$	2,909
Provision for exit and realignment activities	532			807			1,339
Cash payments, net of sublease income	(411		)	(327		)	(738		)
Accrued exit and realignment costs, March 31, 2014	2,555			955			3,510
Provision for exit and realignment activities	6			2,236			2,242
Cash payments, net of sublease income	(383		)	(1,095		)	(1,478		)
Accrued exit and realignment costs, June 30, 2014	$	2,178		$	2,096		$	4,274

In addition to the exit and realignment accruals in the preceding table, we also incurred $2.9 million of costs that were expensed as incurred for the three months ended June 30, 2015, including $1.2 million in accelerated amortization of an

Table of Contents

information system that has been replaced, $0.8 million in property related costs, $0.7 million in information systems costs, and $0.2 million in other costs. In the first quarter of 2015, we also incurred $6.9 million of costs that were expensed as incurred, including $3.0 million in accelerated amortization of an information system that has been replaced, $1.8 million in facility costs, $1.3 million in labor costs, $0.3 million in information systems costs and $0.5 million in other costs.

For the three months ended June 30, 2014, we recognized $1.9 million in costs that were expensed as incurred, including $0.9 million in property related costs, $0.7 million in labor costs, and $0.2 million in information technology costs. Additional expense in the first quarter of 2014 of $1.3 million were comprised of $0.5 million in relocation costs, $0.5 million in property related costs, and $0.3 million in labor and other costs.

We expect additional exit and realignment charges of approximately $1.7 million over the remainder of 2015 for activities initiated in the Domestic and International segments through June 30, 2015.

Note 7—Retirement Plans

We have a noncontributory, unfunded retirement plan for certain officers and other key employees in the United States. Certain of our foreign subsidiaries also have defined benefit pension plans covering substantially all of their respective employees.

The components of net periodic benefit cost, which are included in selling, general and administrative expenses, for the three and six months ended June 30, 2015 and 2014, were as follows:



	Three Months Ended June 30,				Six Months Ended June 30,
	2015		2014		2015		2014
Service cost	$	32	$	40	$	65	$	75
Interest cost	464		482		929		965
Recognized net actuarial loss	401		202		802		406
Net periodic benefit cost	$	897	$	724	$	1,796	$	1,446

Certain of our foreign subsidiaries have health and welfare plans covering substantially all of their respective employees. Our expense for these plans totaled $0.5 million and $0.5 million for the three months ended June 30, 2015 and 2014 and $1.0 million and $1.0 million for the six months ended June 30, 2015 and 2014.

Note 8—Debt

We have $275 million of 3.875% senior notes due 2021 (the “2021 Notes”) and $275 million of 4.375% senior notes due 2024 (the “2024 Notes”), with interest payable semi-annually. The 2021 Notes were sold at 99.5% of the principal amount with an effective yield of 3.951%. The 2024 Notes were sold at 99.6% of the principal with an effective yield of 4.422%. We have the option to redeem the 2021 Notes and 2024 Notes in part or in whole prior to maturity at a redemption price equal to the greater of 100% of the principal amount or the present value of the remaining scheduled payments discounted at the Treasury Rate plus 30 basis points. As of June 30, 2015 and December 31, 2014, the estimated fair value of the 2021 Notes was $280.7 million and $275.1 million and the estimated fair value of the 2024 Notes was $279.7 million and $283.9 million, respectively.

We have a Credit Agreement with a $450 million borrowing capacity which extends through September 2019. Under the Amended Credit Agreement, we have the ability to request two one-year extensions and to request an increase in aggregate commitments by up to $200 million. The interest rate on the Amended Credit Agreement, which is subject to adjustment quarterly, is based on the London Interbank Offered Rate (LIBOR), the Federal Funds Rate or the Prime Rate, plus an adjustment based on the better of our debt ratings or leverage ratio (Credit Spread) as defined by the Amended Credit Agreement. We are charged a commitment fee of between 12.5 and 25.0 basis points on the unused portion of the facility. The terms of the Amended Credit Agreement limit the amount of indebtedness that we may incur and require us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition. Based on our leverage ratio at June 30, 2015, the interest rate under the credit facility is LIBOR plus 1.375%.

At June 30, 2015, we had no borrowings and letters of credit of approximately $5.0 million outstanding under the Amended Credit Agreement, leaving $445 million available for borrowing. We also have a $1.2 million letter of credit outstanding as of June 30, 2015 and December 31, 2014, which supports our facilities leased in Europe.

The Amended Credit Agreement and senior notes contain cross-default provisions which could result in the acceleration of payments due in the event of default of either agreement. We believe we were in compliance with our debt covenants at June 30, 2015.

Table of Contents

Note 9—Derivatives

When deemed appropriate, we use derivatives, primarily forward contracts, as a risk management tool to mitigate the potential impact of foreign currency exchange risk. The total notional values of our foreign currency derivatives was $5.7 million at June 30, 2015 and $10.0 million as of December 31, 2014. We do not currently have any derivatives designated as hedging instruments and all gains and losses resulting from changes in the fair value of derivative instruments are immediately recognized into earnings. At June 30, 2015 and December 31, 2014 the fair value of our foreign currency contracts included in other assets on the consolidated balance sheet was $0.9 million and $0.7 million. The impact from changes in the fair value of these foreign currency derivatives included in other operating expense was $0.5 million and other operating income was $0.3 million for the three and six months ended June 30, 2015. We did not hold foreign currency contracts in the first six months of 2014. We consider the risk of counterparty default to be minimal.

Note 10—Income Taxes

The effective tax rate was 41.2% and 42.7% for the three and six months ended June 30, 2015, compared to 41.1% and 40.9% in the same periods of 2014. The change in rate is mainly due to the impact of foreign taxes and the effect of certain acquisition-related costs which are not deductible for tax purposes. The liability for unrecognized tax benefits was $6.0 million at June 30, 2015, and $6.7 million at December 31, 2014. Included in the liability at June 30, 2015 were $3.6 million of tax positions for which ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. In the current quarter, the Company concluded the examinations of our 2012 and 2013 federal income tax returns. The impact of these examinations on our financial statements was not material.

Note 11—Net Income per Common Share

The following summarizes the calculation of net income per common share attributable to common shareholders for the three and six months ended June 30, 2015 and 2014.



	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands, except per share data)	2015			2014			2015			2014
Numerator:
Net income	$	24,226		$	19,876		$	43,166		$	45,362
Less: income allocated to unvested restricted shares	(195		)	(159		)	(359		)	(345		)
Net income attributable to common shareholders - basic	24,031			19,717			42,807			45,017
Add: undistributed income attributable to unvested restricted shares - basic	42			19			63			68
Less: undistributed income attributable to unvested restricted shares - diluted	(42		)	(19		)	(63		)	(68		)
Net income attributable to common shareholders - diluted	$	24,031		$	19,717		$	42,807		$	45,017
Denominator:
Weighted average shares outstanding - basic	62,226			62,311			62,281			62,271
Dilutive shares - stock options	—			5			1			9
Weighted average shares outstanding - diluted	62,226			62,316			62,282			62,280
Net income per share attributable to common shareholders:
Basic	$	0.39		$	0.32		$	0.69		$	0.72
Diluted	$	0.39		$	0.32		$	0.69		$	0.72

Note 12—Shareholders’ Equity

Our Board of Directors has authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2017. The program is intended, in part, to offset shares issued in conjunction with our stock incentive plans and return capital to shareholders. The program may be suspended or discontinued at any time. During the six months ended June 30, 2015, we repurchased in open-market transactions and retired approximately 0.2 million shares of our common stock for an aggregate of $7.4 million, or an average price per share of $33.82. As of June 30, 2015, we have approximately $82.6 million remaining under the repurchase program. We have elected to allocate any excess of share repurchase price over par value to retained earnings.

Table of Contents

Note 13—Accumulated Other Comprehensive Income

The following table shows the changes in accumulated other comprehensive income (loss) by component for the three and six months ended June 30, 2015 and 2014:



	Defined Benefit Pension Plans				Currency Translation Adjustments			Other			Total
Accumulated other comprehensive income (loss), March 31, 2015	$	(10,065	)		$	(41,588	)	$	7		$	(51,646	)
Other comprehensive income (loss) before reclassifications	—				6,606			—			6,606
Income tax	—				—			—			—
Other comprehensive income (loss) before reclassifications, net of tax	—				6,606			—			6,606
Amounts reclassified from accumulated other comprehensive income (loss)	401				—			(8		)	393
Income tax	(141		)		—			—			(141		)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax	260			—	—			(8		)	252
Other comprehensive income (loss)	260				6,606			(8		)	6,858
Accumulated other comprehensive income (loss), June 30, 2015	$	(9,805	)		$	(34,982	)	$	(1	)	$	(44,788	)

Accumulated other comprehensive income (loss), March 31, 2014	$	(6,372	)		$	16,359		$	146		$	10,133
Other comprehensive income (loss) before reclassifications	—				(570		)	29			(541		)
Income tax	—				—			—			—
Other comprehensive income (loss) before reclassifications, net of tax	—				(570		)	29			(541		)
Amounts reclassified from accumulated other comprehensive income (loss)	202				—			(22		)	180
Income tax	(90		)		—			8			(82		)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax	112				—			(14		)	98
Other comprehensive income (loss)	112				(570		)	15			(443		)
Accumulated other comprehensive income (loss), June 30, 2014	$	(6,260	)		$	15,789		$	161		$	9,690

Table of Contents



	Defined Benefit Pension Plans			Currency Translation Adjustments			Other			Total
Accumulated other comprehensive income (loss), December 31, 2014	$	(10,323	)	$	(13,647	)	$	(31	)	$	(24,001	)
Other comprehensive income (loss) before reclassifications	—			(21,335		)	—			(21,335		)
Income tax	—			—			—			—
Other comprehensive income (loss) before reclassifications, net of tax	—			(21,335		)	—			(21,335		)
Amounts reclassified from accumulated other comprehensive income (loss)	803			—			30			833
Income tax	(285		)	—			—			(285		)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax	518			—			30			548
Other comprehensive income (loss)	518			(21,335		)	30			(20,787		)
Accumulated other comprehensive income (loss), June 30, 2015	$	(9,805	)	$	(34,982	)	$	(1	)	$	(44,788	)

Accumulated other comprehensive income (loss), December 31, 2013	$	(6,479	)	$	15,892		$	155		$	9,568
Other comprehensive income (loss) before reclassifications	—			(103		)	31			(72		)
Income tax	—			—			—			—
Other comprehensive income (loss) before reclassifications, net of tax	—			(103		)	31			(72		)
Amounts reclassified from accumulated other comprehensive income (loss)	405			—			(41		)	364
Income tax	(186		)	—			16			(170		)
Amounts reclassified from accumulated other comprehensive income (loss), net of tax	219			—			(25		)	194
Other comprehensive income (loss)	219			(103		)	6			122
Accumulated other comprehensive income (loss), June 30, 2014	$	(6,260	)	$	15,789		$	161		$	9,690

We include amounts reclassified out of accumulated other comprehensive income related to defined benefit pension plans as a component of net periodic pension cost recorded in selling, general & administrative expenses. For the three and six months ended June 30, 2015, we reclassified $0.4 million and $0.8 million of actuarial net losses. For the three and six months ended June 30, 2014, we reclassified $0.2 million and $0.4 million of actuarial net losses.

Note 14—Commitments and Contingencies

Prior to exiting the direct-to-consumer business in January 2009, we received reimbursements from Medicare, Medicaid, and private healthcare insurers for certain customer billings. We are subject to audits of these reimbursements for up to seven years from the date of the service.

In the first quarter of 2015, we settled our dispute and terminated the service contract with a customer in the United Kingdom. As part of the settlement, we entered into a transition agreement for the transfer of services back to this customer and paid approximately $3.9 million that was fully accrued at December 31, 2014. Substantially all outstanding accounts receivable as of December 31, 2014 related to this contract have been received.

Note 15—Segment Information

We evaluate the performance of our segments based on their operating earnings excluding acquisition-related and exit and realignment charges, certain purchase price fair value adjustments, and other substantive items that, either as a result of their nature or size, would not be expected to occur as part of the our normal business operations on a regular basis.

Table of Contents

The following tables present financial information by segment:



	Three Months Ended June 30,						Six Months Ended June 30,
	2015			2014			2015			2014
Net revenue:
Domestic	$	2,317,661		$	2,187,535		$	4,603,296		$	4,336,451
International	104,506			118,323			210,067			225,788
Consolidated net revenue	$	2,422,167		$	2,305,858		$	4,813,363		$	4,562,239

Operating earnings (loss):
Domestic	$	52,390		$	48,317		$	102,901		$	101,053
International	1,177			(3,623		)	1,557			(6,811		)
Acquisition-related and exit and realignment charges⁽¹⁾	(5,707		)	(7,593		)	(15,623		)	(10,855		)
Consolidated operating earnings	$	47,860		$	37,101		$	88,835		$	83,387

Depreciation and amortization:
Domestic	$	10,504		$	8,812		$	21,242		$	17,787
International	5,277			5,080			10,708			9,969
Consolidated depreciation and amortization	$	15,781		$	13,892		$	31,950		$	27,756

Capital expenditures:
Domestic	$	3,384		$	18,858		$	12,035		$	29,033
International	7,875			5,737			10,790			9,790
Consolidated capital expenditures	$	11,259		$	24,595		$	22,825		$	38,823



	June 30, 2015		December 31, 2014
Total assets:
Domestic	$	2,130,996	$	2,139,972
International	462,941		538,662
Segment assets	2,593,937		2,678,634
Cash and cash equivalents	200,969		56,772
Consolidated total assets	$	2,794,906	$	2,735,406

⁽¹⁾The three and six months ended June 30, 2015 include $1.2 million and $4.2 million, respectively in accelerated amortization related to an information system that is being replaced.

Table of Contents

Note 16—Condensed Consolidating Financial Information

The following tables present condensed consolidating financial information for: Owens & Minor, Inc. (O&M); the guarantors of Owens & Minor, Inc.’s 2021 Notes and 2024 Notes, on a combined basis; and the non-guarantor subsidiaries of the 2021 Notes and 2024 Notes, on a combined basis. The guarantor subsidiaries are 100% owned by Owens & Minor, Inc. Separate financial statements of the guarantor subsidiaries are not presented because the guarantees by our guarantor subsidiaries are full and unconditional, as well as joint and several, and we believe the condensed consolidating financial information is more meaningful in understanding the financial position, results of operations and cash flows of the guarantor subsidiaries.



Three Months Ended June 30, 2015	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Statements of Income
Net revenue	$	—		$	2,279,725		$	178,844		$	(36,402	)	$	2,422,167
Cost of goods sold	—			2,064,515			95,570			(36,255		)	2,123,830
Gross margin	—			215,210			83,274			(147		)	298,337
Selling, general and administrative expenses	626			160,348			70,524			—			231,498
Acquisition-related and exit and realignment charges	—			256			5,451			—			5,707
Depreciation and amortization	—			8,910			6,550			—			15,460
Other operating income, net	—			(1,354		)	(834		)	—			(2,188		)
Operating earnings (loss)	(626		)	47,050			1,583			(147		)	47,860
Interest expense (income), net	6,938			(233		)	(25		)	—			6,680
Income (loss) before income taxes	(7,564		)	47,283			1,608			(147		)	41,180
Income tax (benefit) provision	—			16,973			(19		)	—			16,954
Equity in earnings of subsidiaries	31,790			—			—			(31,790		)	—
Net income (loss)	24,226			30,310			1,627			(31,937		)	24,226
Other comprehensive income (loss)	6,858			(21,839		)	28,696			(6,857		)	6,858
Comprehensive income (loss)	$	31,084		$	8,471		$	30,323		$	(38,794	)	$	31,084

Table of Contents



Three Months Ended June 30, 2014	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Statements of Income
Net revenue	$	—		$	2,187,130		$	137,683		$	(18,955	)	$	2,305,858
Cost of goods sold	—			1,978,815			63,299			(18,528		)	2,023,586
Gross margin	—			208,315			74,384			(427		)	282,272
Selling, general and administrative expenses	61			152,122			73,655			—			225,838
Acquisition-related and exit and realignment charges	—			3,886			3,707			—			7,593
Depreciation and amortization	2			8,790			5,100			—			13,892
Other operating income, net	—			(814		)	(1,338		)	—			(2,152		)
Operating earnings (loss)	(63		)	44,331			(6,740		)	(427		)	37,101
Interest expense (income), net	2,924			791			(373		)	—			3,342
Income (loss) before income taxes	(2,987		)	43,540			(6,367		)	(427		)	33,759
Income tax (benefit) provision	(1,200		)	17,808			(2,725		)	—			13,883
Equity in earnings of subsidiaries	21,663			—			—			(21,663		)	—
Net income (loss)	19,876			25,732			(3,642		)	(22,090		)	19,876
Other comprehensive income (loss)	(443		)	111			(570		)	459			(443		)
Comprehensive income (loss)	$	19,433		$	25,843		$	(4,212	)	$	(21,631	)	$	19,433



Six Months Ended June 30, 2015	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Statements of Income
Net revenue	$	—		$	4,529,430		$	360,204		$	(76,271	)	$	4,813,363
Cost of goods sold	—			4,098,327			195,608			(76,510		)	4,217,425
Gross margin	—			431,103			164,596			239			595,938
Selling, general and administrative expenses	665			320,925			143,733			—			465,323
Acquisition-related and exit and realignment charges	—			3,833			11,790			—			15,623
Depreciation and amortization	—			18,014			13,315			—			31,329
Other operating income, net	—			(2,331		)	(2,841		)	—			(5,172		)
Operating earnings (loss)	(665		)	90,662			(1,401		)	239			88,835
Interest expense (income), net	12,885			581			94			—			13,560
Income (loss) before income taxes	(13,550		)	90,081			(1,495		)	239			75,275
Income tax (benefit) provision	(773		)	31,759			1,123			—			32,109
Equity in earnings of subsidiaries	55,943			—			—			(55,943		)	—
Net income (loss)	43,166			58,322			(2,618		)	(55,704		)	43,166
Other comprehensive income (loss)	(20,787		)	(21,335		)	548			20,787			(20,787		)
Comprehensive income (loss)	$	22,379		$	36,987		$	(2,070	)	$	(34,917	)	$	22,379

Table of Contents



Six Months Ended June 30, 2014	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Statements of Income
Net revenue	$	—		$	4,335,495		$	257,558		$	(30,814	)	$	4,562,239
Cost of goods sold	—			3,918,280			110,897			(30,406		)	3,998,771
Gross margin	—			417,215			146,661			(408		)	563,468
Selling, general and administrative expenses	14			306,372			145,062			—			451,448
Acquisition-related and exit and realignment charges	—			5,180			5,675			—			10,855
Depreciation and amortization	1			17,741			10,014			—			27,756
Other operating income, net	—			(7,877		)	(2,101		)	—			(9,978		)
Operating earnings (loss)	(15		)	95,799			(11,989		)	(408		)	83,387
Interest expense (income), net	5,399			2,034			(844		)	—			6,589
Income (loss) before income taxes	(5,414		)	93,765			(11,145		)	(408		)	76,798
Income tax (benefit) provision	(2,155		)	37,994			(4,403		)	—			31,436
Equity in earnings of subsidiaries	48,621			—			—			(48,621		)	—
Net income (loss)	45,362			55,771			(6,742		)	(49,029		)	45,362
Other comprehensive income (loss)	122			218			(103		)	(115		)	122
Comprehensive income (loss)	$	45,484		$	55,989		$	(6,845	)	$	(49,144	)	$	45,484

Table of Contents



June 30, 2015	Owens & Minor, Inc.			Guarantor Subsidiaries			Non- guarantor Subsidiaries			Eliminations			Consolidated
Balance Sheets
Assets
Current assets
Cash and cash equivalents	$	105,427		$	46,639		$	48,903		$	—		$	200,969
Accounts and notes receivable, net	—			485,256			105,346			(9,863		)	580,739
Merchandise inventories	—			852,396			55,272			(4,167		)	903,501
Other current assets	299			94,214			179,717			1,251			275,481
Total current assets	105,726			1,478,505			389,238			(12,779		)	1,960,690
Property and equipment, net	—			108,373			110,999			—			219,372
Goodwill, net	—			247,271			174,489			—			421,760
Intangible assets, net	—			14,768			86,136			—			100,904
Due from O&M and subsidiaries	—			513,448			—			(513,448		)	—
Advances to and investment in consolidated subsidiaries	1,897,461			—			—			(1,897,461		)	—
Other assets, net	4,347			62,413			25,420			—			92,180
Total assets	$	2,007,534		$	2,424,778		$	786,282		$	(2,423,688	)	$	2,794,906
Liabilities and equity
Current liabilities
Accounts payable	$	—		$	713,907		$	48,470		$	(8,882	)	$	753,495
Accrued payroll and related liabilities	—			23,485			11,312			—			34,797
Deferred income taxes	—			43,160			(1,782		)	—			41,378
Other accrued liabilities	7,004			99,024			182,404			—			288,432
Total current liabilities	7,004			879,576			240,404			(8,882		)	1,118,102
Long-term debt, excluding current portion	547,905			5,395			21,323			—			574,623
Due to O&M and subsidiaries	475,498			—			77,464			(552,962		)	—
Intercompany debt	—			138,890			—			(138,890		)	—
Deferred income taxes	—			32,974			29,308			—			62,282
Other liabilities	—			55,155			7,617			—			62,772
Total liabilities	1,030,407			1,111,990			376,116			(700,734		)	1,817,779
Equity
Common stock	126,036			—			—			—			126,036
Paid-in capital	205,727			241,877			514,314			(756,191		)	205,727
Retained earnings (deficit)	690,152			1,080,701			(69,099		)	(1,011,602		)	690,152
Accumulated other comprehensive income (loss)	(44,788		)	(9,790		)	(35,049		)	44,839			(44,788		)
Total equity	977,127			1,312,788			410,166			(1,722,954		)	977,127
Total liabilities and equity	$	2,007,534		$	2,424,778		$	786,282		$	(2,423,688	)	$	2,794,906

Table of Contents



December 31, 2014	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Balance Sheets
Assets
Current assets
Cash and cash equivalents	$	22,013		$	3,912		$	30,847		$	—		$	56,772
Accounts and notes receivable, net	—			519,951			144,463			(38,222		)	626,192
Merchandise inventories	—			816,915			60,061			(4,519		)	872,457
Other current assets	(24,748		)	90,733			224,220			25,080			315,285
Total current assets	(2,735		)	1,431,511			459,591			(17,661		)	1,870,706
Property and equipment, net	—			110,076			122,903			—			232,979
Goodwill, net	—			247,271			176,005			—			423,276
Intangible assets, net	—			15,805			92,788			—			108,593
Due from O&M and subsidiaries	—			357,304			—			(357,304		)	—
Advances to and investments in consolidated subsidiaries	1,893,767			—			—			(1,893,767		)	—
Other assets, net	4,637			66,836			28,379			—			99,852
Total assets	$	1,895,669		$	2,228,803		$	879,666		$	(2,268,732	)	$	2,735,406
Liabilities and equity
Current liabilities
Accounts payable	$	—		$	567,285		$	54,898		$	(13,337	)	$	608,846
Accrued payroll and related liabilities	—			16,434			15,073			—			31,507
Deferred income taxes	—			39,667			(1,688		)	—			37,979
Other current liabilities	6,441			83,698			236,084			—			326,223
Total current liabilities	6,441			707,084			304,367			(13,337		)	1,004,555
Long-term debt, excluding current portion	547,763			39,915			20,873			—			608,551
Due to O&M and subsidiaries	350,627			—			77,788			(428,415		)	—
Intercompany debt	—			138,890			—			(138,890		)	—
Deferred income taxes	—			33,162			30,739			—			63,901
Other liabilities	—			55,794			11,767			—			67,561
Total liabilities	904,831			974,845			445,534			(580,642		)	1,744,568
Equity													—
Common stock	126,140			—			—			—			126,140
Paid-in capital	202,934			241,877			514,314			(756,191		)	202,934
Retained earnings (deficit)	685,765			1,022,379			(66,479		)	(955,900		)	685,765
Accumulated other comprehensive income (loss)	(24,001		)	(10,298		)	(13,703		)	24,001			(24,001		)
Total equity	990,838			1,253,958			434,132			(1,688,090		)	990,838
Total liabilities and equity	$	1,895,669		$	2,228,803		$	879,666		$	(2,268,732	)	$	2,735,406

Table of Contents



Six Months Ended June 30, 2015	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Statements of Cash Flows
Operating activities:
Net income (loss)	$	43,166		$	58,322		$	(2,618	)	$	(55,704	)	$	43,166
Adjustments to reconcile net income to cash provided by (used for) operating activities:
Equity in earnings of subsidiaries	(55,943		)	—			—			55,943			—
Depreciation and amortization	—			17,741			18,397			—			36,138
Share-based compensation expense	—			5,048			—			—			5,048
Provision for losses on accounts and notes receivable	—			(36		)	77			—			41
Deferred income tax expense (benefit)	—			2,376			616			—			2,992
Changes in operating assets and liabilities:
Accounts and notes receivable	—			35,566			(180		)	6,236			41,622
Merchandise inventories	—			(35,481		)	1,193			2,422			(31,866		)
Accounts payable	—			146,622			5,798			(6,738		)	145,682
Net change in other assets and liabilities	(148		)	14,338			(9,260		)	(2,159		)	2,771
Other, net	429			726			41			—			1,196
Cash provided by (used for) operating activities	(12,496		)	245,222			14,064			—			246,790
Investing activities:
Additions to property and equipment	—			(9,292		)	(2,717		)	—			(12,009		)
Additions to computer software and intangible assets	—			(2,068		)	(8,748		)	—			(10,816		)
Proceeds from the sale of property and equipment	—			60			777			—			837
Cash used for investing activities	—			(11,300		)	(10,688		)	—			(21,988		)
Financing activities:
Change in intercompany advances	135,627			(155,951		)	20,324			—			—
Repayment of revolving credit facility	—			(33,700		)	—			—			(33,700		)
Change in bank overdraft	—			—			1,530			—			1,530
Cash dividends paid	(31,867		)	—			—			—			(31,867		)
Repurchases of common stock	(7,440		)	—			—			—			(7,440		)
Excess tax benefits related to share-based compensation	457			—			—			—			457
Other, net	(867		)	(1,544		)	(2,701		)	—			(5,112		)
Cash provided by (used for) financing activities	95,910			(191,195		)	19,153			—			(76,132		)
Effect of exchange rate changes on cash and cash equivalents	—			—			(4,473		)	—			(4,473		)
Net increase (decrease) in cash and cash equivalents	83,414			42,727			18,056			—			144,197
Cash and cash equivalents at beginning of period	22,013			3,912			30,847			—			56,772
Cash and cash equivalents at end of period	$	105,427		$	46,639		$	48,903		$	—		$	200,969

Table of Contents



Six months ended June 30, 2014	Owens & Minor, Inc.			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations			Consolidated
Statements of Cash Flows
Operating activities:
Net income (loss)	$	45,362		$	55,771		$	(6,742	)	$	(49,029	)	$	45,362
Adjustments to reconcile net income to cash provided by (used for) operating activities:
Equity in earnings of subsidiaries	(48,621		)	—			—			48,621			—
Depreciation and amortization	1			17,741			10,014			—			27,756
Share-based compensation expense	—			4,190			—			—			4,190
Provision for losses on accounts and notes receivable	—			146			188			—			334
Deferred income tax expense (benefit)	—			(4,117		)	(1,034		)	—			(5,151		)
Changes in operating assets and liabilities:
Accounts and notes receivable	—			28,286			428			(237		)	28,477
Merchandise inventories	—			(38,733		)	(10,248		)	406			(48,575		)
Accounts payable	—			54,860			(177		)	239			54,922
Net change in other assets and liabilities	(952		)	(15,272		)	(16,541		)	—			(32,765		)
Other, net	(776		)	(280		)	(22		)	—			(1,078		)
Cash provided by (used for) operating activities	(4,986		)	102,592			(24,134		)	—			73,472
Investing activities:
Proceeds from the sale of investment				1,937									1,937
Additions to property and equipment	—			(16,777		)	(8,880		)	—			(25,657		)
Additions to computer software and intangible assets	—			(12,256		)	(910		)	—			(13,166		)
Proceeds from the sale of property and equipment	—			35			10			—			45
Cash used for investing activities	—			(27,061		)	(9,780		)	—			(36,841		)
Financing activities:
Change in intercompany advances	28,847			(62,995		)	34,148			—			—
Cash dividends paid	(31,564		)	—			—			—			(31,564		)
Repurchases of common stock	(9,448		)	—			—			—			(9,448		)
Excess tax benefits related to share-based compensation	444			—			—			—			444
Proceeds from exercise of stock options	1,180			—			—			—			1,180
Purchase of noncontrolling interest	—			—			(1,500		)	—			(1,500		)
Other, net	(2,072		)	(1,450		)	(919		)	—			(4,441		)
Cash provided by (used for) financing activities	(12,613		)	(64,445		)	31,729			—			(45,329		)
Effect of exchange rate changes on cash and cash equivalents	—			—			(1,180		)	—			(1,180		)
Net increase (decrease) in cash and cash equivalents	(17,599		)	11,086			(3,365		)	—			(9,878		)
Cash and cash equivalents at beginning of period	74,391			2,012			25,502			—			101,905
Cash and cash equivalents at end of period	$	56,792		$	13,098		$	22,137		$	—		$	92,027

Table of Contents

Note 17—Recent Accounting Pronouncements

There has been no change in our significant accounting policies from those contained in our Annual Report on Form 10-K for the year ended December 31, 2014. There are no new accounting pronouncements that we anticipate will have a material impact on our financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis describes results of operations and material changes in the financial condition of Owens & Minor, Inc. and its subsidiaries since December 31, 2014. Trends of a material nature are discussed to the extent known and considered relevant. This discussion should be read in conjunction with the consolidated financial statements, related notes thereto, and management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the year ended December 31, 2014.

Overview

Owens & Minor, Inc., along with its subsidiaries, (we, us, or our) is a leading national distributor of name-brand medical and surgical supplies and a healthcare logistics company. We report our business under two segments: Domestic and International. The Domestic segment includes all functions relating to our role as a medical supply logistics company providing distribution, packaging and logistics services to healthcare providers and manufacturers in the United States. The International segment consists of our European third-party logistics and packaging businesses. Segment financial information is provided in Note 15 of Notes to Consolidated Financial Statements included in this quarterly report.

Financial highlights. The following table provides a reconciliation of reported operating earnings, net income and net income per diluted common share to non-GAAP measures used by management.



	Three Months Ended June 30,						Six Months Ended June 30,
(Dollars in thousands except per share data)	2015			2014			2015			2014
Operating earnings, as reported (GAAP)	$	47,860		$	37,101		$	88,835		$	83,387
Acquisition-related and exit and realignment charges	5,707			7,593			15,623			10,855
Operating earnings, adjusted (non-GAAP) (Adjusted Operating Earnings)	$	53,567		$	44,694		$	104,458		$	94,242
Adjusted Operating Earnings as a percent of revenue (non-GAAP)	2.21		%	1.94		%	2.17		%	2.07		%
Net income, as reported (GAAP)	$	24,226		$	19,876		$	43,166		$	45,362
Acquisition-related and exit and realignment charges, net of tax	4,869			5,095			13,461			7,317
Net income, adjusted (non-GAAP) (Adjusted Net Income)	$	29,095		$	24,971		$	56,627		$	52,679
Net income per diluted common share, as reported (GAAP)	$	0.39		$	0.32		$	0.69		$	0.72
Acquisition-related and exit and realignment charges, per diluted common share	0.07			0.08			0.21			0.12
Net income per diluted common share, adjusted (non-GAAP)(Adjusted EPS)	$	0.46		$	0.40		$	0.90		$	0.84

Adjusted EPS (non-GAAP) was $0.46 and $0.90 for the three and six months ended June 30, 2015, $0.06 higher than the prior year for both periods. Domestic segment operating earnings increased by $4.1 million to $52.4 million in the second quarter and increased $1.8 million to $102.9 million for the year-to-date period when compared to prior year. The six month period of 2014 included the recovery of $5.3 million related to the settlement of a direct purchaser anti-trust class action lawsuit. The International segment improved $4.8 million in the three month period ended June 30, 2015 to operating income of $1.2 million and improved $8.4 million on a year-to-date basis to operating income of $1.6 million.

Use of Non-GAAP Measures

This management’s discussion and analysis contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP). In general, the measures exclude items and charges that (i) management does not believe reflect our core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate our performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation.

Table of Contents

Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results and in comparing our performance to that of our competitors. However, the non-GAAP financial measures used by us may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

The non-GAAP financial measures disclosed by us should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated.

Acquisition-related charges were $1.8 million and $4.4 million for the three and six months ended June 30, 2015 compared to $3.5 million and $4.1 million for the same periods of 2014. Current year charges consist primarily of costs to continue the integration of Medical Action and ArcRoyal which were acquired in the fourth quarter of 2014 including certain severance and contractual payments to former management and costs to transition information technology and other administrative functions. Prior year charges consisted primarily of transaction costs incurred to perform due diligence and analysis related to these acquisitions, as well as costs in Movianto to resolve certain contingencies with the former owner.

Exit and realignment charges of $3.9 million and $11.2 million for the three and six months ended June 30, 2015 were associated with optimizing our operations and included the consolidation of distribution and logistics centers and closure of offsite warehouses in the United States and Europe, as well as other costs associated with our strategic organizational realignment which include certain professional fees and costs to streamline administrative functions and processes in Europe. Similar charges in 2014 totaled $4.1 million and $6.7 million in the comparable periods.

These charges have been tax effected in the preceding table by determining the income tax rate depending on the amount of charges incurred in different tax jurisdictions and the deductibility of those charges for income tax purposes. Unless otherwise stated, our analysis hereinafter excludes acquisition-related and exit and realignment charges. More information about these charges is provided in Notes 3 and 6 of Notes to Consolidated Financial Statements included in this quarterly report.

Results of Operations

Net revenue.



	Three Months Ended June 30,				Change
(Dollars in thousands)	2015		2014		$			%
Domestic	$	2,317,661	$	2,187,535	$	130,126		5.9	%
International	104,506		118,323		(13,817		)	(11.7	)%
Net revenue	$	2,422,167	$	2,305,858	$	116,309		5.0	%



	Six Months Ended June 30,				Change
(Dollars in thousands)	2015		2014		$			%
Domestic	$	4,603,296	$	4,336,451	$	266,845		6.2	%
International	210,067		225,788		(15,721		)	(7.0	)%
Net revenue	$	4,813,363	$	4,562,239	$	251,124		5.5	%

Consolidated net revenue improved in the three and six month periods ended June 30, 2015 as a result of strong growth in our Domestic segment. Excluding the impact of the 2014 fourth quarter acquisition, Domestic net revenue increased by 4.2% for the quarter and 4.5% year-to-date. The continued trend of growth in our existing large healthcare provider customer accounts and new business exceeded declines from smaller customers and lost business when compared to prior year. Domestic segment growth rates are impacted by ongoing market trends including healthcare utilization rates. The decrease in the International segment net revenue was driven by unfavorable foreign currency translation impacts of $15.7 million and $30.5 million for the three and six months ended June 30, 2015. On a constant currency basis, excluding the impact of the 2014 packaging acquisition and the transition of a customer from buy/sell to a fee-for-service arrangement, net revenues in the International segment were essentially flat for the quarter and year-to-date periods compared to prior year. Fee-for-service business generally represents approximately two-thirds of net revenue in the International segment.

Table of Contents

Cost of goods sold.



	Three Months Ended June 30,				Change
(Dollars in thousands)	2015		2014		$		%
Cost of goods sold	$	2,123,830	$	2,023,586	$	100,244	5.0	%



	Six Months Ended June 30,				Change
(Dollars in thousands)	2015		2014		$		%
Cost of goods sold	$	4,217,425	$	3,998,771	$	218,654	5.5	%

Cost of goods sold includes the cost of the product (net of supplier incentives and cash discounts) and all costs incurred for shipments of products from manufacturers to our distribution centers for all customer arrangements where we are the primary obligor, bear risk of general and physical inventory loss and carry all credit risk associated with sales. These are sometimes referred to as distribution or buy/sell contracts. Beginning in the fourth quarter of 2014, cost of goods sold also includes direct and certain indirect labor, material and overhead costs associated with our packaging operations. There is no cost of goods sold associated with our fee-for-service business. As a result of the increase in sales activity through our distribution and packaging businesses, cost of goods sold increased from prior year by $100.2 million and $218.7 million for the three and six month periods ended June 30, 2015, respectively.

Gross margin.



	Three Months Ended June 30,						Change
(Dollars in thousands)	2015			2014			$		%
Gross margin	$	298,337		$	282,272		$	16,065	5.7	%
As a % of net revenue	12.32		%	12.24		%



	Six Months Ended June 30,						Change
(Dollars in thousands)	2015			2014			$		%
Gross margin	$	595,938		$	563,468		$	32,470	5.8	%
As a % of net revenue	12.38		%	12.35		%

The increases in gross margin for the quarter and year-to-date periods of 2015 compared to the prior year were largely attributable to revenue growth in the Domestic segment as described above, as well as benefits from certain supplier product price changes in the second quarter of 2015. The International segment also experienced an increase in gross margin from prior year resulting from the packaging acquisition and growth in fee-for-service business though these benefits were offset by $12.6 million in the quarter and $23.8 million year-to-date in unfavorable impacts from foreign currency translation.

Operating expenses.



	Three Months Ended June 30,						Change
(Dollars in thousands)	2015			2014			$			%
SG&A expenses	$	231,498		$	225,838		$	5,660		2.5	%
As a % of net revenue	9.56		%	9.79		%
Depreciation and amortization	$	15,460		$	13,892		$	1,568		11.3	%
Other operating income, net	$	(2,188	)	$	(2,152	)	$	(36	)	1.7	%



	Six Months Ended June 30,						Change
(Dollars in thousands)	2015			2014			$		%
SG&A expenses	$	465,323		$	451,448		$	13,875	3.1	%
As a % of net revenue	9.67		%	9.90		%
Depreciation and amortization	$	31,329		$	27,756		$	3,573	12.9	%
Other operating income, net	$	(5,172	)	$	(9,978	)	$	4,806	(48.2	)%

Table of Contents

Selling, general and administrative (SG&A) expenses include labor and warehousing costs associated with our distribution and logistics services and all costs associated with our fee-for-service arrangements. Shipping and handling costs are included in SG&A expenses and include costs to store, to move, and to prepare products for shipment, as well as costs to deliver products to customers. The costs to convert new customers to our information systems are generally incurred prior to the recognition of revenues from the new customers.

The increases in SG&A expenses compared to the prior year periods were largely attributable to increased expenses associated with incremental sales activity in the Domestic segment as well as increases from the 2014 acquisitions in both segments, partially offset by favorable foreign currency translation impacts of $11.4 million for the quarter and $22.1 million year-to-date. The Domestic segment also incurred $0.4 million and $0.8 million for the three and six month periods ended June 30, 2015 in costs associated with our previously announced CEO search which includes professional fees, consulting, meeting and travel expenses and other costs associated with the leadership succession plan.

Depreciation and amortization expense increased in both periods of 2015 compared to the prior year as a result of property, equipment and intangible assets acquired with business combinations in the fourth quarter of 2014. In connection with our packaging businesses, approximately $0.3 million and $0.6 million in depreciation for the three and six months ended June 20, 2015 is also included in cost of goods sold. Additional amortization of $1.2 million and $4.2 million related to the accelerated amortization of an information system which has been replaced in the International segment is included in acquisition-related and exit and realignment charges for the current quarter and year-to-date periods.

The decrease in other operating income, net for the six months ended June 30, 2015 compared to 2014 was attributed primarily to the benefit in the prior year of $5.3 million from the settlement of a direct purchaser anti-trust class action lawsuit which did not re-occur in the current year.

Interest expense, net



	Three Months Ended June 30,						Change
(Dollars in thousands)	2015			2014			$		%
Interest expense, net	$	6,680		$	3,342		$	3,338	99.9	%
Effective interest rate	4.81		%	6.12		%



	Six Months Ended June 30,						Change
(Dollars in thousands)	2015			2014			$		%
Interest expense, net	$	13,560		$	6,589		$	6,971	105.8	%
Effective interest rate	4.74		%	6.10		%

The increases in interest expense in the three and six months ended June 30, 2015 compared to the same periods of 2014 were the result of the new Senior Notes issued on September 16, 2014.

Income taxes.



	Three Months Ended June 30,						Change
(Dollars in thousands)	2015			2014			$		%
Income tax provision	$	16,954		$	13,883		$	3,071	22.1	%
Effective tax rate	41.2		%	41.1		%



	Six Months Ended June 30,						Change
(Dollars in thousands)	2015			2014			$		%
Income tax provision	$	32,109		$	31,436		$	673	2.1	%
Effective tax rate	42.7		%	40.9		%

The change in the provision for income taxes compared to 2014, including income taxes on acquisition-related and exit and realignment charges, is a result of the amount of pretax income earned in different tax jurisdictions and the deductibility of certain acquisition-related charges for income tax purposes.

Table of Contents

Financial Condition, Liquidity and Capital Resources

Financial condition. We monitor operating working capital through days sales outstanding (DSO) and merchandise inventory turnover. We estimate a hypothetical increase (decrease) in DSO of one day would result in a decrease (increase) in our cash balances, an increase (decrease) in borrowings against our revolving credit facility, or a combination thereof of approximately $25 million.

The majority of our cash and cash equivalents are held in cash depository accounts with major banks in the United States and Europe or invested in high-quality, short-term liquid investments. Changes in our working capital can vary in the normal course of business based upon the timing of inventory purchases, collection of accounts receivable, and payment to suppliers.



	June 30, 2015		December 31, 2014		Change
(Dollars in thousands)	June 30, 2015		December 31, 2014		$			%
Cash and cash equivalents	$	200,969	$	56,772	$	144,197		254.0	%
Accounts and notes receivable, net of allowances	$	580,739	$	626,192	$	(45,453	)	(7.3	)%
Consolidated DSO ⁽¹⁾	20.4		22.1
Merchandise inventories	$	903,501	$	872,457	$	31,044		3.6	%
Consolidated inventory turnover ⁽²⁾	9.6		10.1
Accounts payable	$	753,495	$	608,846	$	144,649		23.8	%

(1) Based on period end accounts receivable and net revenue for the quarter

(2) Based on average annual inventory and annualized cost of goods sold based on the quarter ended June 30, 2015 and December 31, 2014

Liquidity and capital expenditures. The following table summarizes our consolidated statements of cash flows for the six months ended June 30, 2015 and 2014:



(Dollars in thousands)	2015			2014
Net cash provided by (used for):
Operating activities	$	246,790		$	73,472
Investing activities	(21,988		)	(36,841		)
Financing activities	(76,132		)	(45,329		)
Effect of exchange rate changes	(4,473		)	(1,180		)
Increase (decrease) in cash and cash equivalents	$	144,197		$	(9,878	)

Cash provided by operating activities was $246.8 million in the first six months of 2015, compared to $73.5 million in the same period of 2014. The increase in cash from operating activities for the first six months of 2015 compared to the same period in 2014 was primarily due to timing of payments to vendors and improvements in net working capital.

Cash used for investing activities was $22.0 million in the first six months of 2015, compared to $36.8 million in the same period of 2014. Investing activities in 2015 and 2014 related to capital expenditures for our strategic and operational efficiency initiatives, particularly initiatives relating to information technology enhancements and optimizing our distribution network.

Cash used for financing activities in the first six months of 2015 was $76.1 million, compared to $45.3 million used in the same period of 2014. During the first six months of 2015, we paid dividends of $31.9 million (compared to $31.6 million in 2014), repurchased common stock under a share repurchase program for $7.4 million (compared to $9.4 million in 2014) and repaid $33.7 million in borrowings on our Amended Credit Agreement. Financing activities in 2014 also included proceeds of $1.2 million from the exercise of stock options and the cash purchase of the noncontrolling interest in a subsidiary for $1.5 million.

Capital resources. Our sources of liquidity include cash and cash equivalents and a revolving credit facility. On September 17, 2014, we amended our existing Credit Agreement with Wells Fargo Bank, N.A., JPMorgan Chase Bank, N.A., Bank of America, N.A. and a syndicate of financial institutions (the Amended Credit Agreement) increasing our borrowing capacity from $350 million to $450 million and extending the term through 2019. Under the Amended Credit Agreement, we have the ability to request two one-year extensions and to request an increase in aggregate commitments by up to $200 million. The interest rate on the Amended Credit Agreement, which is subject to adjustment quarterly, is based on the London Interbank Offered Rate (LIBOR), the Federal Funds Rate or the Prime Rate, plus an adjustment based on the better of our debt ratings or leverage ratio (Credit Spread) as defined by the Amended Credit Agreement. We are charged a commitment fee of between 12.5 and 25.0 basis points on the unused portion of the facility. The terms of the Amended Credit Agreement limit the amount

Table of Contents

of indebtedness that we may incur and require us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition. We may utilize the revolving credit facility for long-term strategic growth, capital expenditures, working capital and general corporate purposes. If we were unable to access the revolving credit facility, it could impact our ability to fund these needs. Based on our leverage ratio at June 30, 2015, the interest rate under the credit facility is LIBOR plus 1.375%.

At June 30, 2015 , we had no borrowings and letters of credit of approximately $5.0 million outstanding under the Amended Credit Agreement, leaving $445 million available for borrowing. We also have a $1.2 million letter of credit outstanding as of June 30, 2015 and December 31, 2014 which supports our facilities leased in Europe.

On September 16, 2014, we issued $275 million of 3.875% senior notes due 2021 (the “2021 Notes”) and $275 million of 4.375% senior notes due 2024 (the “2024 Notes”). The 2021 Notes were sold at 99.5% of the principal amount with an effective yield of 3.951%. The 2024 Notes were sold at 99.6% of the principal amount with an effective yield of 4.422%. Interest on the 2021 Notes and 2024 Notes is payable semiannually in arrears, commencing on March 15, 2015 and December 15, 2014, respectively. We have the option to redeem the 2021 Notes and 2024 Notes in part or in whole prior to maturity at a redemption price equal to the greater of 100% of the principal amount or the present value of the remaining scheduled payments discounted at the Treasury Rate plus 30 basis points.

In the second quarter of 2015, we paid cash dividends on our outstanding common stock at the rate of $0.2525 per share, which represents a 1.0% increase over the rate of $0.25 per share paid in the second quarter of 2014. We anticipate continuing to pay quarterly cash dividends in the future. However, the payment of future dividends remains within the discretion of the Board of Directors and will depend upon our results of operations, financial condition, capital requirements and other factors.

In February 2014, the Board of Directors authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2017. The program is intended, in part, to offset shares issued in conjunction with our stock incentive plan and return capital to shareholders. The program may be suspended or discontinued at any time. Purchases under the share repurchase program are made either pursuant to 10b5-1 plans entered into by the company from time to time and/or during the company’s scheduled quarterly trading windows for officers and directors. During the first six months of 2015, we repurchased approximately 0.2 million shares for $7.4 million under this program. At June 30, 2015, the remaining amount authorized for repurchase under this program was $82.6 million.

We earn a portion of our operating earnings in foreign jurisdictions outside the U.S., which we consider to be indefinitely reinvested. Accordingly, no U.S. federal and state income taxes and withholding taxes have been provided on these earnings. Our cash, cash-equivalents, short-term investments, and marketable securities held by our foreign subsidiaries totaled $39.7 million and $31.5 million as of June 30, 2015 and December 31, 2014. We do not intend, nor do we foresee a need, to repatriate these funds or other assets held outside the U.S. In the future, should we require more capital to fund discretionary activities in the U.S. than is generated by our domestic operations and is available through our borrowings, we could elect to repatriate cash or other assets from foreign jurisdictions that have previously been considered to be indefinitely reinvested.

We believe available financing sources, including cash generated by operating activities and borrowings under the Amended Credit Agreement, will be sufficient to fund our working capital needs, capital expenditures, long-term strategic growth, payments under long-term debt and lease arrangements, payments of quarterly cash dividends, share repurchases and other cash requirements. While we believe that we will have the ability to meet our financing needs in the foreseeable future, changes in economic conditions may impact (i) the ability of financial institutions to meet their contractual commitments to us, (ii) the ability of our customers and suppliers to meet their obligations to us or (iii) our cost of borrowing.

Recent Accounting Pronouncements

For a discussion of recent accounting pronouncements, see Note 17 in the Notes to Consolidated Financial Statements, included in this Quarterly Report on Form 10-Q for the quarterly period ended on June 30, 2015.

Forward-looking Statements

Certain statements in this discussion constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Although we believe our expectations with respect to the forward-looking statements are based upon reasonable assumptions within the bounds of our knowledge of our business and operations, all forward-looking statements involve risks and uncertainties and, as a result, actual results could differ materially from those projected, anticipated or implied by these statements. Such forward-looking statements involve known and unknown risks, including, but not limited to:


•	competitive pressures in the marketplace, including intense pricing pressure;

Table of Contents


•	our ability to retain existing and attract new customers in a market characterized by significant customer consolidation and intense cost-containment initiatives;


•	our dependence on sales to certain customers or the loss or material reduction in purchases by key customers;


•	our dependence on distribution of product of certain suppliers;


•	our ability to successfully identify, manage or integrate acquisitions;


•	our ability to successfully manage our international operations, including risks associated with changes in international trade regulations, foreign currency volatility, changes in regulatory conditions, deteriorating economic conditions, adverse tax consequences, and other risks of operating in international markets;


•	uncertainties related to and our ability to adapt to changes in government regulations, including healthcare laws and regulations (including the Affordable Care Act);


•	risks arising from possible violations of legal, regulatory or licensing requirements of the markets in which we operate;


•	uncertainties related to general economic, regulatory and business conditions;


•	our ability to successfully implement our strategic initiatives;


•	the availability of and modifications to existing supplier funding programs and our ability to meet the terms to qualify for certain of these programs;


•	our ability to adapt to changes in product pricing and other terms of purchase by suppliers of product;


•	the ability of customers and suppliers to meet financial commitments due to us;


•	changes in manufacturer preferences between direct sales and wholesale distribution;


•	changing trends in customer profiles and ordering patterns and our ability to meet customer demand for additional value-added services;


•	our ability to manage operating expenses and improve operational efficiencies in response to changing customer profiles;


•	our ability to meet performance targets specified by customer contracts under contractual commitments;


•	availability of and our ability to access special inventory buying opportunities;


•	the ability of business partners and financial institutions to perform their contractual responsibilities;


•	the effect of price volatility in the commodities markets, including fuel price fluctuations, on our operating costs and supplier product prices;


•	our ability to continue to obtain financing at reasonable rates and to manage financing costs and interest rate risk;


•	the risk that information systems are interrupted or damaged or fail for any extended period of time, that new information systems are not successfully implemented or integrated, or that there is a data security breach in our information systems;


•	the risk that a decline in business volume or profitability could result in an impairment of goodwill or other long-lived assets;


•	our ability to timely or adequately respond to technological advances in the medical supply industry;


•	the costs associated with and outcome of outstanding and any future litigation, including product and professional liability claims;


•	adverse changes in U.S. and foreign tax laws and the outcome of outstanding tax contingencies and legislative and tax proposals; and


•	other factors described in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2014.

We undertake no obligation to update or revise any forward-looking statements, except as required by applicable law.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from changes in interest rates related to our revolving credit facility. We had no outstanding borrowings and approximately $5 million in letters of credit under the revolving credit facility at June 30, 2015. A hypothetical increase in interest rates of 100 basis points would result in a potential reduction in future pre-tax earnings of approximately $0.1 million per year for every $10 million of outstanding borrowings under the revolving credit facility.

Due to the nature and pricing of our Domestic segment distribution services, we are exposed to potential volatility in fuel prices. Our strategies for helping to mitigate our exposure to changing domestic fuel prices has included entering into leases for trucks with improved fuel efficiency and entering into fixed–price agreements for diesel fuel. We benchmark our domestic diesel fuel purchase prices against the U.S. Weekly Retail On-Highway Diesel Prices (benchmark) as quoted by the U.S. Energy Information Administration. The benchmark averaged $2.88 per gallon in the first six months of 2015, a decrease from $3.94 per gallon in the first six months of 2014. Based on our fuel consumption in the first six months of 2015, we estimate that every 10 cents per gallon increase in the benchmark would reduce our Domestic segment operating earnings by approximately $0.3 million on an annualized basis.

In the normal course of business, we are exposed to foreign currency translation and transaction risks. Our business transactions outside of the United States are primarily denominated in the Euro and British Pound. We may use foreign currency forwards, swaps and options, where possible, to manage our risk related to certain foreign currency fluctuations. However, we believe that our foreign currency transaction risks are low since our revenues and expenses are typically denominated in the same currency.

Item 4. Controls and Procedures

We carried out an evaluation, with the participation of management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (pursuant to Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, the principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of June 30, 2015. There has been no change in our internal control over financial reporting during the quarter ended June 30, 2015, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

SEC guidance permits the exclusion of an evaluation of the effectiveness of a registrant's disclosure controls and procedures as they relate to the internal control over financial reporting for an acquired business during the first year following such acquisition. In the fourth quarter of 2014, we acquired Medical Action and ArcRoyal. These acquisitions represented $323 million of total assets and $95.2 million of net revenues as of and for the six months ended June 30, 2015. Management's evaluation and conclusion as to the effectiveness of the design and operation of the Company's disclosure controls and procedures as of and for the period covered by this report excludes any evaluation of the internal control over financial reporting of these acquisitions.

Part II. Other Information

Item 1. Legal Proceedings

Certain legal proceedings pending against us are described in our Annual Report on Form 10-K for the year ended December 31, 2014. Through June 30, 2015, there have been no material developments in any legal proceedings reported in such Annual Report.

Item 1A. Risk Factors

Certain risk factors that we believe could affect our business and prospects are described in our Annual Report on Form 10-K for the year ended December 31, 2014. Through June 30, 2015, there have been no material changes in the risk factors described in such Annual Report.

Table of Contents

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities

In February 2014, our Board of Directors authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2017. The program is intended, in part, to offset shares issued in conjunction with our stock incentive plan and return capital to shareholders. The program may be suspended or discontinued at any time. Purchases under the share repurchase program are made either pursuant to 10b5-1 plans entered into by the company from time to time and/or during the company’s scheduled quarterly trading windows for officers and directors. For the three months ended June 30, 2015, we repurchased in open-market transactions and retired 220 thousand shares of our common stock for an aggregate of $7.4 million, or an average price per share of $33.82. The following table summarizes share repurchase activity by month during the three months ended June 30, 2015.



Period	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of a publicly announced program	Maximum dollar value of shares that may yet be purchased under the program
April 2015	10,000	$	34.12	10,000	$	89,658,675
May 2015	100,000	$	33.74	100,000	$	86,282,178
June 2015	110,000	$	33.82	110,000	$	82,560,246
Total	220,000			220,000

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



		Owens & Minor, Inc.
		(Registrant)

Date:	July 28, 2015	/s/ P. Cody Phipps
		P. Cody Phipps
		President & Chief Executive Officer

Date:	July 28, 2015	/s/ Richard A. Meier
		Richard A. Meier
		Executive Vice President & Chief Financial Officer

Table of Contents

Item 6. Exhibits


(a)	Exhibits



10.1		Agreement dated February 14, 2015 Regarding Retirement of James L. Bierman

10.2		Employment Term Sheet effective May 20, 2015 for P. Cody Phipps

10.3		Restricted Stock Grant Agreement dated July 1, 2015 between the Company and P. Cody Phipps

10.4		Owens & Minor, Inc. Officer Severance Policy

10.5		Amended Form of Annual Executive Incentive Program

10.6		Form of Director Restricted Stock Grant Agreement under Owens & Minor, Inc. 2015 Stock Incentive Plan

10.7		Form of Officer Restricted Stock Grant Agreement under Owens & Minor, Inc. 2015 Stock Incentive Plan

10.8		Form of Performance Share Award Agreement under Owens & Minor, Inc. 2015 Stock Incentive Plan

31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Definition Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document